Clinical Practice and Prognosis of Stage IV Colorectal Cancer-Reference-Cited by-同舟云学术

Clinical Practice and Prognosis of Stage IV Colorectal Cancer

Published:2024-03-01 Issue:3 Volume:57 Page:109-116
ISSN:0386-9768
Container-title:The Japanese Journal of Gastroenterological Surgery
language:en
Short-container-title:Jpn J Gastroenterol Surg

Author:

Mashiko Ryutaro¹²,Honda Michitaka¹²,Kawamura Hideaki¹,Todate Yukitoshi¹²,Miyakawa Teppei¹²,Nakao Eiichi¹²,Toshiyama Satoshi¹²,Yamamoto Ryuya¹²,Takano Yoshinao²

Affiliation:

1. Department of Minimally Invasive Surgical and Medical Oncology, Fukushima Medical University

2. Department of Surgery, South Tohoku General Hospital

Publisher

The Japanese Journal of Gastroenterological Surgery

Link

https://www.jstage.jst.go.jp/article/jjgs/57/3/57_2023.0025/_pdf

Reference25 articles.

1. 1) Katanoda K, Hori M, Saito E, Shibata A, Ito Y, Minami T, et al. Updated trends in cancer in Japan: Incidence in 1985–2015 and mortality in 1958–2018—A Sign of decrease in cancer incidence. J Epidemiol. 2021 Jul;31(7):426–450.

2. 2) Yamada Y, Takahari D, Matsumoto H, Baba H, Nakamura M, Yoshida K, et al. Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial. Lancet Oncol. 2013 Dec;14(13):1278–1286.

3. 3) 国立がん研究センターがん情報サービス．院内がん登録生存率集計結果閲覧システム，大腸がん5年生存率［Internet］．［cited 2023 Feb 15］Available from: https://hbcr-survival.ganjoho.jp/graph?year=2013-2014&elapsed=5&type=c02#h-title

4. 4) Hori M, Matsuda T, Shibata A, Katanoda K, Sobue T, Nishimoto H; Japan Cancer Surveillance Research Group. Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol. 2015 Sep;45(9):884–891.

5. 5) 大腸癌研究会．全国大腸癌登録報告書，Vol. 39［Internet］．［cited 2023 Feb 5］Available from: https://www.jsccr.jp/registration/report.html